Carolina Research Professionals, LLC: Clinical Trials

2 completed, 1 unknown. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 2

Follow Carolina Research Professionals, LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Post-eRADicAte - A Long Term Follow up of Subjects That Completed the eRADicAte Study (NCT 02097303) Prostate Cancer Metastatic		Unknown	Carolina Research Professionals, LLC	31	2017-10-01	2019-03-19
Open Label Phase Two Study of Enzalutamide With Concurrent Administration of Radium Ra 223 Dichloride in Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Symptomatic Bone Metastasis Enzalutamide, Radium ra 223 dichloride - Prostate Carcinoma Metastatic to the Bone	Phase 2	Completed	Carolina Research Professionals, LLC	40	2015-09-23	2019-03-19
Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis Concurrent use of Radium Ra 223 dichloride and Abiraterone Acetate plus Prednisone - Prostate Cancer	Phase 2	Completed	Carolina Research Professionals, LLC	36	2014-03-01	2018-02-01

Conditions studied

Prostatic Neoplasms (1)

Interventions

radium Ra 223 dichloride (2)  ·  Abiraterone Acetate (1)  ·  Prednisone (1)  ·  enzalutamide (1)

Countries

United States (3)

Top investigators

Neal D Shore, MD (2)